Navigation Links
New Research on the Transcatheter Aortic Valve Market Now Available
Date:3/8/2013

DUBLIN, March 8, 2013 /PRNewswire/ --

Research and Markets (http://www.researchandmarkets.com/research/fhjghw/transcatheter) has announced the addition of the "TransCatheter Aortic Valves Market" report to their offering.

The global transcatheter aortic heart valve opportunity continues to be strong and growing. Edwards reported 2012 sales of $552 and predicts it will manage to generate $780 million globally in 2013, including $420 million in the US alone. Our analysts forecast a $2.2 billion global market by 2018.

     (Logo: http://photos.prnewswire.com/prnh/20130307/600769)

Interventional cardiologists are exceptionally enthusiastic about the potential of transcatheter aortic valve replacement, and with good reason. The preliminary data on this new treatment modality show that the procedure provides a minimally invasive alternative to cardiac valve surgery.

The average age for patients diagnosed with severe aortic stenosis is 70 years. Traditional valve replacement is considered a high risk surgery for most of these elderly patients.

Furthermore, a significant percentage of patients diagnosed with moderate or severe valve disease have been denied traditional valve surgery, due to its high operative mortality rate.

Transcatheter aortic valve implantation (TAVI) has been established as an alternative to surgical aortic valve replacement in inoperable and high-risk patients with severe, symptomatic aortic stenosis.

Next-generation transcatheter aortic valves will facilitate the procedure, improve outcome and usability and address remaining TAVI-specific drawbacks such as periprosthetic aortic regurgitation.

The TransCatheter Aortic Valves Market report is targeted at senior executives in the medical device industry who wish to get up-to-date with this multi-billion dollar fast growing market. The report offers a consensus-based linear forecast to to 2018.

Key Topics Covered:

1. Executive Summary

2. Aortic Stenosis

3. TransCatheter Aortic Valve Technology

4. TransCatheter Aortic Valves Market

5. The Future of TransCatheter Aortic Valves

6. Company in the Space

List of Tables & Figures:

For more information visit http://www.researchandmarkets.com/research/fhjghw/transcatheter

Research and Markets
Laura Wood , Senior Manager.
press@researchandmarkets.com
U.S. Fax: +1-646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Medical Devices, Cardiovascular Devices


'/>"/>
SOURCE Research and Markets
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Janssen Launches EXPLORER, Global Cardiovascular Research Program, Beginning with Five New Studies in Patients with Unmet Medical Needs
2. Pipeline Initiatives, Partnerships to Drive Growth - Research Report on Pfizer, Theravance, ISIS Pharmaceuticals, Infinity Pharmaceuticals and Ironwood
3. Accelovance Expansion Continues with Acquisition of Radiant Development, the CRO Division of Radiant Research
4. AVANIR PHARMACEUTICALS ANNOUNCES RESEARCH COLLABORATION WITH DEPARTMENT OF VETERANS AFFAIRS FOR SCREENING PSEUDOBULBAR AFFECT (PBA) SYMPTOMS IN VETERANS WITH TRAUMATIC BRAIN INJURY
5. Todays Research on PDL BioPharma, Dendreon, Medivation, ACADIA Pharma, and Cell Therapeutics
6. Global Gynecological Devices Market is Expected to Reach USD 5.3 Billion by 2018: Transparency Market Research
7. Texas A&M Research Contributes To Improved Ultrasound Imaging
8. Diabetes Research Institute Tests BioHub Mini Organ to Restore Natural Insulin Production in Type 1 Diabetes
9. Presage Biosciences Announces Strategic Research Alliance with Celgene Corporation
10. AMBI Supports Skin of Color Society Research Award
11. Synteract und Harrison Clinical Research vereinbaren die Gründung eines multinationalen Auftragsforschungsinstituts
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/12/2016)... North Carolina , 12 februari 2016 ... Inc. (AAI/CML), een toonaangevende leverancier van productie ... en biotechnologische industrieën, kondigt vandaag een uitbreiding ... mogelijkheden op haar locatie in ... vraag heeft geleid tot meerdere recente investeringen. ...
(Date:2/12/2016)... 2016 --> ... Inflammation Global Clinical Trials Review, H2, 2015 provides ... clinical trials landscape along with top level data ... (G7 & E7), Trial Status, Trial Phase, Sponsor ... companies involved and enlists all trials (Trial title, ...
(Date:2/11/2016)... 2016 Stem cells are primitive cells found ... and the capacity to differentiate into mature cell types ... the first mouse embryonic stem cells were derived from ... that the first culturing of embryonic stem cells from ... produced until 2006 As a result of these discoveries, ...
Breaking Medicine Technology:
(Date:2/12/2016)... ... February 12, 2016 , ... According to an ... beginning to account for a significant portion of hernia repairs throughout the United States. ... Beverly Hills Hernia Center notes that this trend has not only been expected, but ...
(Date:2/12/2016)... ... ... CDRH Enforcement Trends: , Back to the Future , Feb. 25, 2016 — 11:00 a.m. ... “Those who don’t learn from history are doomed to repeat it.” , An analysis of ... year. But that takes time. , Take a close look at the warning letters ...
(Date:2/12/2016)... ... 2016 , ... T.E.N., a technology and information security executive ... Awards 2016. Finalists and winners of the ISE® Awards for both Executive and ... Gala on March 15, 2016 at the Westin Peachtree Plaza, Atlanta. , ...
(Date:2/12/2016)... ... , ... AssureVest Insurance Group, a locally owned insurance firm with offices serving ... funds earmarked to purchase computers and software for Mrs. Harrison’s 2nd and 3rd grade ... a low-income area and has more than 60 2nd and 3rd graders with learning ...
(Date:2/12/2016)... San Ramon, CA (PRWEB) , ... February 12, 2016 , ... ... tissue donation in northern California and Nevada, announced a partnership with San Ramon Regional ... be transferred to the hospital’s facilities as a way to accommodate a more certain ...
Breaking Medicine News(10 mins):